23andMe Inc. is a prominent biotechnology company specializing in genetic testing and personal genomics. Founded in 2006, the company offers direct-to-consumer DNA testing services that provide insights into genetic health risks, ancestry, and traits. Its innovative approach to personal genomics has made it a leader in the consumer genetics market.
Market Position 23andMe holds a strong position in the genetic testing industry, characterized by:
Browse Our Research Portfolio In 23andMe Inc. Markets
Health Care
Health Care
Information Technology
Health Care Providers and Services
Health Care Providers and Services
Biotechnology
Software
Health Care Services
Health Care Services
Biotechnology
Application Software
About Technavio
With unparalleled market insights, our research is designed to elevate your business to new heights. Technavio stands at the forefront of market research with a global perspective. Our approach is grounded in four key principles: accessible reports, comprehensive industry analysis, a focus on innovative and emerging technologies, and competitive pricing. We are dedicated to empowering companies and executives to make informed, timely, and strategic decisions.